The question is can these visits overcome industry's propaganda delivered under the guise of continuing medical education (CME) courses which physicians must take?
Netracor J & J heart Drug May Raise Risk of Dying Wed, 20 Apr 2005 A new research challenges the safety level linked with the drug ‘Natretor.’ Scios Inc., a subsidiary of Johnson & Johnson is the maker of “Natrecor.” “Researchers say . . . Continue reading →
Suspended Chief Medical Officer of Medicare reassigned to AHRQ Wed, 21 Sep 2005 An example of how little the federal government cares about professinal standards or the integrity of high ranking medical offficers. Contact: Vera Hassner Sharav 212-595-8974 Daily Health Policy Report . . . Continue reading →
When Doctors Learn, Drug Firms Often Pay th eTab – Philly Inquirer Wed, 8 Jun 2005 The Philadelphia Inquirer reports about the blinders that academic medical institutions and physicians (in this instance psychiatrists) put on pretending not to know that they have . . . Continue reading →
Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry– Multi-Discipline Conference_ NYC Mon, 4 Oct 2004 An Op Ed article in The Washington Post by Shannon Brownlee (below) nails the elite procurers of psychotropic drugs who have long denied the ominous signals . . . Continue reading →
When Doctors Go to Class, Industry Often Foots the Bill – WSJ Fri, 6 Dec 2002 A front page article in The Wall Street Journal by Scott Hensley sheds further light on the corruption of medical ethics by focusing on a drug . . . Continue reading →
Almost 1/2 of faculty on IRBs have ties to industry – Harvard Partners Fri, 15 Aug 2003 A survey by faculty at the Institute for Health Policy, Massachusetts General Hospital (MGH) and Harvard Medical School found that “Consulting relationships with industry are . . . Continue reading →
Two probing first rate investigative reports document how psychiatry’s treatments are shaped by "opinion leaders" whose professional recommendations are compromised by their substantial, largely undisclosed, financial ties to drug companies. Continue reading →
Once again, the New England Journal of Medicine (July 13, 2006) has had to eat crow after it published false and misleading clinical trial findings.
Continue reading →
Psychiatry’s professional practice paradigm has received a major blow. Continue reading →
"32% of the advertisements [in peer reviewed journals] misled readers regarding efficacy, 40% did not provide balanced descriptions of the side effects, and 44% could lead to improper prescribing if the physician did not use other sources of information regarding the drug." Continue reading →
Correction! A panel calling itself the Institute of Medicine as a Profession (IMP) is calling for a ban on the intermingling of industry and academic scholars and physicians. This is NOT affiliated with the Institute of Medicine (IOM)
Continue reading →